Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study
dc.contributor.author | Tasci, Elif Senocak | |
dc.contributor.author | Oyan, Basak | |
dc.contributor.author | Sonmez, Ozlem | |
dc.contributor.author | Mutlu, Arda Ulas | |
dc.contributor.author | Atci, Muhammed Mustafa | |
dc.contributor.author | Oner, Irem | |
dc.contributor.author | Cinkir, Havva Yesil | |
dc.date.accessioned | 2024-02-23T14:31:12Z | |
dc.date.available | 2024-02-23T14:31:12Z | |
dc.date.issued | 2022 | |
dc.department | NEÜ | en_US |
dc.description | ASCO Gastrointestinal Cancers Symposium -- JAN 20-22, 2022 -- San Francisco, CA | en_US |
dc.description.abstract | [Abstract Not Availabe] | en_US |
dc.description.sponsorship | Amer Soc Clin Oncol | en_US |
dc.identifier.doi | 10.1200/JCO.2022.40.4_suppl.202 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.issn | 1527-7755 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.uri | https://doi.org/10.1200/JCO.2022.40.4_suppl.202 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/15089 | |
dc.identifier.volume | 40 | en_US |
dc.identifier.wos | WOS:000770995900198 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Journal Of Clinical Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [Keyword Not Available] | en_US |
dc.title | Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study | en_US |
dc.type | Conference Object | en_US |